Lipidomics for studying metabolism

Nature Reviews Endocrinology

Volumn 12, Issue 11, 2016, Pages 668-679

  Han, Xianlin ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; FATTY ACID; GLYCEROLIPID; GLYCEROPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PLASMALOGEN; SPHINGOLIPID;

BIOINFORMATICS; HUMAN; ION MOBILITY MASS SPECTROMETRY; LIPID METABOLISM; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW; SHOTGUN LIPIDOMICS;

EID: 84979971887     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.98     Document Type: Review

References (153)

1. Kishimoto, K., Urade, R., Ogawa, T. & Moriyama, T. Nondestructive quantification of neutral lipids by thinlayer chromatography and laser-fluorescent scanning: suitable methods for ?lipidome? analysis. Biochem. Biophys. Res. Commun. 281, 657-662 (2001).
2. Yetukuri, L. et al. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst. Biol. 1, 12 (2007).
3. Han, X. & Jiang, X. A review of lipidomic technologies applicable to sphingolipidomics and their relevant applications. Eur. J. Lipid Sci. Technol. 111, 39-52 (2009).
4. Yang, K., Cheng, H., Gross, R. W. & Han, X. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem. 81, 4356-4368 (2009).
5. Fahy, E. et al. A comprehensive classification system for lipids. J. Lipid Res. 46, 839-861 (2005).
6. Han, X. & Gross, R. W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44, 1071-1079 (2003).
7. Lagarde, M., Geloen, A., Record, M., Vance, D. & Spener, F. Lipidomics is emerging. Biochim. Biophys. Acta 1634, 61 (2003).
8. Lee, S. H., Williams, M. V., DuBois, R. N. & Blair, I. A. Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. Rapid Commun. Mass Spectrom. 17, 2168-2176 (2003).
9. Esch, S. W., Williams, T. D., Biswas, S., Chakrabarty, A. & Levine, S. M. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach. Cell. Mol. Biol. 49, 779-787 (2003).
10. Cheng, H., Xu, J., McKeel, D. W. Jr & Han, X. Specificity and potential mechanism of sulfatide deficiency in Alzheimer?s disease: an electrospray ionization mass spectrometric study. Cell. Mol. Biol. 49, 809-818 (2003).
11. Han, X., Yang, K. & Gross, R. W. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom. Rev. 31, 134-178 (2012).
12. Blanksby, S. J. & Mitchell, T. W. Advances in mass spectrometry for lipidomics. Annu. Rev. Anal. Chem. 3, 433-465 (2010).
13. Vance, D. E. & Vance, J. E. Biochemistry of Lipids, Lipoproteins and Membranes (Elsevier Science, 2008).
14. Han, X. & Gross, R. W. Shotgun lipidomics: multidimensional mass spectrometric analysis of cellular lipidomes. Expert Rev. Proteomics 2, 253-264 (2005).
15. Han, X., Yang, K. & Gross, R. W. Microfluidics-based electrospray ionization enhances intrasource separation of lipid classes and extends identification of individual molecular species through multi-dimensional mass spectrometry: development of an automated high throughput platform for shotgun lipidomics. Rapid Commun. Mass Spectrom. 22, 2115-2124 (2008).
16. Han, X. & Gross, R. W. Structural determination of lysophospholipid regioisomers by electrospray ionization tandem mass spectrometry. J. Am. Chem. Soc. 118, 451-457 (1996).
17. Yang, K., Zhao, Z., Gross, R. W. & Han, X. Systematic analysis of choline-containing phospholipids using multi-dimensional mass spectrometry-based shotgun lipidomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2924-2936 (2009).
18. Wang, M., Han, R. H. & Han, X. Fatty acidomics: global analysis of lipid species containing a carboxyl group with a charge-remote fragmentation-assisted approach. Anal. Chem. 85, 9312-9320 (2013).
19. Wang, M., Wang, C., Han, R. H. & Han, X. Novel advances in shotgun lipidomics for biology and medicine. Prog. Lipid Res. 61, 83-108 (2016).
20. Kofeler, H. C., Fauland, A., Rechberger, G. N. & Trotzmuller, M. Mass spectrometry based lipidomics: an overview of technological platforms. Metabolites 2, 19-38 (2012).
21. Cajka, T. & Fiehn, O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt. Chem. 61, 192-206 (2014).
22. Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299-3305 (2010).
23. Henning, P. A., Merrill, A. H. & Wang, M. D. Dynamic pathway modeling of sphingolipid metabolism. Conf. Proc. IEEE Eng. Med. Biol. Soc. 4, 2913-2916 (2004).
24. Kiebish, M. A. et al. Dynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics. J. Lipid Res. 51, 2153-2170 (2010).
25. Zarringhalam, K. et al. Statistical analysis of the processes controlling choline and ethanolamine glycerophospholipid molecular species composition. PLoS ONE 7, e37293 (2012).
26. Han, R. H., Wang, M., Fang, X. & Han, X. Simulation of triacylglycerol ion profiles: bioinformatics for interpretation of triacylglycerol biosynthesis. J. Lipid Res. 54, 1023-1032 (2013).
27. Wakelam, M. J., Pettitt, T. R. & Postle, A. D. Lipidomic analysis of signaling pathways. Methods Enzymol. 432, 233-246 (2007).
28. Griffiths, W. J. Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids. Mass Spectrom. Rev. 22, 81-152 (2003).
29. Griffiths, W. J. & Wang, Y. Analysis of neurosterols by GC-MS and LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2778-2805 (2009).
30. Vanier, M. T. Lysosomal diseases: biochemical pathways and investigations. Handb. Clin. Neurol. 113, 1695-1699 (2013).
31. Selvaraj, S., Krishnaswamy, S., Devashya, V., Sethuraman, S. & Krishnan, U. M. Influence of membrane lipid composition on flavonoid-membrane interactions: implications on their biological activity. Prog. Lipid Res. 58, 1-13 (2015).
32. Gault, C. R., Obeid, L. M. & Hannun, Y. A. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688, 1-23 (2010).
33. Merrill, A. H. Jr et al. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J. Lipid Res. 50, S97-S102 (2009).
34. Wang, C., Wang, M. & Han, X. Applications of mass spectrometry for cellular lipid analysis. Mol. Biosyst. 11, 698-713 (2015).
35. Pruett, S. T. et al. Biodiversity of sphingoid bases (?sphingosines?) and related amino alcohols. J. Lipid Res. 49, 1621-1639 (2008).
36. Zitomer, N. C. et al. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J. Biol. Chem. 284, 4786-4795 (2009).
37. Levy, M. & Futerman, A. H. Mammalian ceramide synthases. IUBMB Life 62, 347-356 (2010).
38. Rodriguez-Cuenca, S., Barbarroja, N. & Vidal-Puig, A. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity. Biochim. Biophys. Acta 1851, 40-50 (2015).
39. Stiban, J., Tidhar, R. & Futerman, A. H. Ceramide synthases: roles in cell physiology and signaling. Adv. Exp. Med. Biol. 688, 60-71 (2010).
40. Lingwood, D. & Simons, K. Lipid rafts as a membraneorganizing principle. Science 327, 46-50 (2010).
41. Rog, T. & Vattulainen, I. Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes? Chem. Phys. Lipids 184, 82-104 (2014).
42. D?Angelo, G., Capasso, S., Sticco, L. & Russo, D. Glycosphingolipids: synthesis and functions. FEBS J. 280, 6338-6353 (2013).
43. Hakomori, S. & Igarashi, Y. Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem. 118, 1091-1103 (1995).
44. Summers, S. A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72 (2006).
45. Chaurasia, B. & Summers, S. A. Ceramides- lipotoxic inducers of metabolic disorders. Trends Endocrinol. Metab. 26, 538-550 (2015).
46. Zhang, C., Klett, E. L. & Coleman, R. A. Lipid signals and insulin resistance. Clin. Lipidol. 8, 659-667 (2013).
47. Vance, J. E. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J. Lipid Res. 49, 1377-1387 (2008).
48. Vance, J. E. & Steenbergen, R. Metabolism and functions of phosphatidylserine. Prog. Lipid Res. 44, 207-234 (2005).
49. Shindou, H. & Shimizu, T. Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. 284, 1-5 (2009).
50. Yang, K., Zhao, Z., Gross, R. W. & Han, X. Shotgun lipidomics identifies a paired rule for the presence of isomeric ether phospholipid molecular species. PLoS ONE 2, e1368 (2007).
51. Fagone, P. & Jackowski, S. Membrane phospholipid synthesis and endoplasmic reticulum function. J. Lipid Res. 50, S311-S316 (2009).
52. Nagan, N. & Zoeller, R. A. Plasmalogens: biosynthesis and functions. Prog. Lipid Res. 40, 199-229 (2001).
53. Mayr, J. A. Lipid metabolism in mitochondrial membranes. J. Inherit. Metab. Dis. 38, 137-144 (2015).
54. Feillet-Coudray, C., Fouret, G., Casas, F. & Coudray, C. Impact of high dietary lipid intake and related metabolic disorders on the abundance and acyl composition of the unique mitochondrial phospholipid, cardiolipin. J. Bioenerg. Biomembr. 46, 447-457 (2014).
55. Hishikawa, D., Hashidate, T., Shimizu, T. & Shindou, H. Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J. Lipid Res. 55, 799-807 (2014).
56. Bogdanov, M., Dowhan, W. & Vitrac, H. Lipids and topological rules governing membrane protein assembly. Biochim. Biophys. Acta 1843, 1475-1488 (2014).
57. Pinot, M. et al. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins. Science 345, 693-697 (2014).
58. Cintra, D. E. et al. Lipid profile of rats fed high-fat diets based on flaxseed, peanut, trout, or chicken skin. Nutrition 22, 197-205 (2006).
59. McMahon, H. T. & Boucrot, E. Membrane curvature at a glance. J. Cell Sci. 128, 1065-1070 (2015).
60. Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788 (2010).
61. Unger, R. H. & Scherer, P. E. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 21, 345-352 (2010).
62. Coleman, R. A. & Lee, D. P. Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid Res. 43, 134-176 (2004).
63. Dulloo, A. G., Gubler, M., Montani, J. P., Seydoux, J. & Solinas, G. Substrate cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity. Int. J. Obes. Relat. Metab. Disord. 28, S29-S37 (2004).
64. Bartz, R. et al. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J. Lipid Res. 48, 837-847 (2007).
65. Yang, K., Jenkins, C. M., Dilthey, B. & Gross, R. W. Multidimensional mass spectrometry-based shotgun lipidomics analysis of vinyl ether diglycerides. Anal. Bioanal. Chem. 407, 5199-5210 (2015).
66. Nakamura, M. T. & Nara, T. Y. Structure, function, and dietary regulation of δ6, δ5, and δ9 desaturases. Annu. Rev. Nutr. 24, 345-376 (2004).
67. Nagle, C. A., Klett, E. L. & Coleman, R. A. Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 50, S74-S79 (2009).
68. Christie, W. W. & Han, X. Lipid Analysis: Isolation, Separation, Identification and Lipidomic Analysis (The Oily Press, 2010).
69. Wang, X., Cao, Y., Fu, Y., Guo, G. & Zhang, X. Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease. Lipids Health Dis. 10, 234 (2011).
70. Holloway, P. W. & Wakil, S. J. Synthesis of fatty acids in animal tissues. II. The occurrence and biosynthesis of cis-vaccenic acid. J. Biol. Chem. 239, 2489-2495 (1964).
71. Taniguchi, M. & Okazaki, T. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. Biochim. Biophys. Acta 1841, 692-703 (2014).
72. Shevchenko, A. & Simons, K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11, 593-598 (2010).
73. Kolovou, G., Kolovou, V. & Mavrogeni, S. Lipidomics in vascular health: current perspectives. Vasc. Health Risk Manag. 11, 333-342 (2015).
74. Mancuso, D. J. et al. Genetic ablation of calciumindependent phospholipase A2γ prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation. J. Biol. Chem. 285, 36495-36510 (2010).
75. Cedars, A., Jenkins, C. M., Mancuso, D. J. & Gross, R. W. Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction. J. Cardiovasc. Pharmacol. 53, 277-289 (2009).
76. Balgoma, D., Montero, O., Balboa, M. A. & Balsinde, J. Lipidomic approaches to the study of phospholipase A2-regulated phospholipid fatty acid incorporation and remodeling. Biochimie 92, 645-650 (2010).
77. Brown, H. A., Henage, L. G., Preininger, A. M., Xiang, Y. & Exton, J. H. Biochemical analysis of phospholipase D. Methods Enzymol. 434, 49-87 (2007).
78. Clark, J. et al. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat. Methods 8, 267-272 (2011).
79. Luo, B., Regier, D. S., Prescott, S. M. & Topham, M. K. Diacylglycerol kinases. Cell. Signal. 16, 983-989 (2004).
80. Carman, G. M. & Han, G. S. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J. Biol. Chem. 284, 2593-2597 (2009).
81. Osman, C., Voelker, D. R. & Langer, T. Making heads or tails of phospholipids in mitochondria. J. Cell Biol. 192, 7-16 (2011).
82. Lai, L. et al. A role for peroxisome proliferatoractivated receptor gamma coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis. J. Biol. Chem. 289, 2250-2259 (2014).
83. Infante, J. P. & Huszagh, V. A. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol. Cell. Biochem. 168, 101-115 (1997).
84. Infante, J. P. & Huszagh, V. A. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol. Genet. Metab. 72, 185-198 (2001).
85. Sprecher, H., Luthria, D. L., Mohammed, B. S. & Baykousheva, S. P. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res. 36, 2471-2477 (1995).
86. Lai, L. et al. Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart. Genes Dev. 22, 1948-1961 (2008).
87. Mejia, E. M., Nguyen, H. & Hatch, G. M. Mammalian cardiolipin biosynthesis. Chem. Phys. Lipids 179, 11-16 (2014).
88. Saini-Chohan, H. K. et al. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J. Lipid Res. 50, 1600-1608 (2009).
89. Baile, M. G., Lu, Y. W. & Claypool, S. M. The topology and regulation of cardiolipin biosynthesis and remodeling in yeast. Chem. Phys. Lipids 179, 25-31 (2014).
90. Barth, P. G. et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am. J. Med. Genet. A 126A, 349-354 (2004).
91. Xu, Y., Kelley, R. I., Blanck, T. J. & Schlame, M. Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278, 51380-51385 (2003).
92. Xu, Y., Malhotra, A., Ren, M. & Schlame, M. The enzymatic function of tafazzin. J. Biol. Chem. 281, 39217-39224 (2006).
93. Schlame, M. et al. Deficiency of tetralinoleoylcardiolipin in Barth syndrome. Ann. Neurol. 51, 634-637 (2002).
94. Hauff, K. D. & Hatch, G. M. Cardiolipin metabolism and Barth Syndrome. Prog. Lipid Res. 45, 91-101 (2006).
95. Han, X. et al. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44, 16684-16694 (2005).
96. Han, X. et al. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry 46, 6417-6428 (2007).
97. Sparagna, G. C., Johnson, C. A., McCune, S. A., Moore, R. L. & Murphy, R. C. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J. Lipid Res. 46, 1196-1204 (2005).
98. Kiebish, M. A., Han, X., Cheng, H., Chuang, J. H. & Seyfried, T. N. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 49, 2545-2556 (2008).
99. Kiebish, M. A. et al. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J. Lipid Res. 54, 1312-1325 (2013).
100. Bayir, H. et al. Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann. Neurol. 62, 154-169 (2007).
101. Kagan, V. E. et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223-232 (2005).
102. He, Q. & Han, X. Cardiolipin remodeling in diabetic heart. Chem. Phys. Lipids 179, 75-81 (2014).
103. Beyer, K. & Nuscher, B. Specific cardiolipin binding interferes with labeling of sulfhydryl residues in the adenosine diphosphate/adenosine triphosphate carrier protein from beef heart mitochondria. Biochemistry 35, 15784-15790 (1996).
104. Ott, M., Robertson, J. D., Gogvadze, V., Zhivotovsky, B. & Orrenius, S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl Acad. Sci. USA 99, 1259-1263 (2002).
105. Lewis, R. N. & McElhaney, R. N. The physicochemical properties of cardiolipin bilayers and cardiolipincontaining lipid membranes. Biochim. Biophys. Acta 1788, 2069-2079 (2009).
106. Li, J. et al. Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression. Proc. Natl Acad. Sci. USA 109, 6975-6980 (2012).
107. Schlame, M., Ren, M., Xu, Y., Greenberg, M. L. & Haller, I. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 138, 38-49 (2005).
108. Mancuso, D. J. et al. Genetic ablation of calciumindependent phospholipase A2γ leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J. Biol. Chem. 282, 34611-34622 (2007).
109. Ma, B. J., Taylor, W. A., Dolinsky, V. W. & Hatch, G. M. Acylation of monolysocardiolipin in rat heart. J. Lipid Res. 40, 1837-1845 (1999).
110. Taylor, W. A. & Hatch, G. M. Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 278, 12716-12721 (2003).
111. Cao, J., Liu, Y., Lockwood, J., Burn, P. & Shi, Y. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl- CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279, 31727-31734 (2004).
112. Li, J. et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. 12, 154-165 (2010).
113. Farooqui, A. A. & Horrocks, L. A. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7, 232-245 (2001).
114. Engelmann, B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem. Soc. Trans. 32, 147-150 (2004).
115. Han, X. Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer?s disease. Biochim. Biophys. Acta 1801, 774-783 (2010).
116. Ford, D. A. & Gross, R. W. Identification of endogenous 1-O-alk-1′-enyl-2-acyl-sn-glycerol in myocardium and its effective utilization by choline phosphotransferase. J. Biol. Chem. 263, 2644-2650 (1988).
117. Ejsing, C. S. et al. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal. Chem. 78, 6202-6214 (2006).
118. Siggia, S. & Edsberg, R. L. Iodometric determination of vinyl alkyl ethers. Anal. Chem. 20, 762-763 (1948).
119. Fhaner, C. J., Liu, S., Zhou, X. & Reid, G. E. Functional group selective derivatization and gas-phase fragmentation reactions of plasmalogen glycerophospholipids. Mass Spectrom. (Tokyo) 2, S0015 (2013).
120. Ford, D. A., Hazen, S. L., Saffitz, J. E. & Gross, R. W. The rapid and reversible activation of a calciumindependent plasmalogen-selective phospholipase A2 during myocardial ischemia. J. Clin. Invest. 88, 331-335 (1991).
121. Gross, R. W. High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization. Biochemistry 23, 158-165 (1984).
122. Wang, M., Fang, H. & Han, X. Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization. Anal. Chem. 84, 4580-4586 (2012).
123. Wacker, B. K., Albert, C. J., Ford, B. A. & Ford, D. A. Strategies for the analysis of chlorinated lipids in biological systems. Free Radic. Biol. Med. 59, 92-99 (2013).
124. Murphy, R. C. et al. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346, 1-42 (2005).
125. van den Bosch, H. et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. Biochimie 75, 183-189 (1993).
126. Bechmann, L. P. et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 56, 952-964 (2012).
127. Gross, R. W. & Han, X. Lipidomics in diabetes and the metabolic syndrome. Methods Enzymol. 433, 73-90 (2007).
128. Graessler, J. et al. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE 4, e6261 (2009).
129. Meikle, P. J. & Christopher, M. J. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr. Opin. Lipidol. 22, 210-215 (2011).
130. Martel, C., Esposti, D. D., Bouchet, A., Brenner, C. & Lemoine, A. Non-alcoholic steatohepatitis: new insights from OMICS studies. Curr. Pharm. Biotechnol. 13, 726-735 (2012).
131. Pietilainen, K. H. et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol. 9, e1000623 (2011).
132. Murphy, R. C. Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. Chem. Res. Toxicol. 14, 463-472 (2001).
133. Schmitz, G. & Ecker, J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47, 147-155 (2008).
134. Lopategi, A. et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol. Cell. Endocrinol. 419, 44-59 (2016).
135. Debnath, M., Agrawal, S., Agrawal, A. & Dubey, G. P. Metaflammatory responses during obesity: Pathomechanism and treatment. Obes. Res. Clin. Pract. 10, 103-113 (2016).
136. Hashidate-Yoshida, T. et al. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport. eLife 4, e06328 (2015).
137. Lamaziere, A., Wolf, C., Barbe, U., Bausero, P. & Visioli, F. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 88, 149-154 (2013).
138. Eslamparast, T., Eghtesad, S., Poustchi, H. & Hekmatdoost, A. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J. Hepatol. 7, 204-212 (2015).
139. dos Santos, G. A. et al. Identification of compounds from high-fat and extra virgin olive oil-supplemented diets in whole mouse liver extracts and isolated mitochondria using mass spectrometry. J. Mass Spectrom. 50, 951-958 (2015).
140. Forrester, J. S., Milne, S. B., Ivanova, P. T. & Brown, H. A. Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol. 65, 813-821 (2004).
141. Momin, A. A. et al. A method for visualization of ?omic? datasets for sphingolipid metabolism to predict potentially interesting differences. J. Lipid Res. 52, 1073-1083 (2011).
142. Hornemann, T. et al. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J. Biol. Chem. 284, 26322-26330 (2009).
143. Han, G. et al. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl Acad. Sci. USA 106, 8186-8191 (2009).
144. Shaner, R. L. et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 50, 1692-1707 (2009).
145. Gaspar, M. L. et al. The emergence of yeast lipidomics. Biochim. Biophys. Acta 1771, 241-254 (2007).
146. Dickson, R. C. Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast. J. Lipid Res. 49, 909-921 (2008).
147. Ejsing, C. S. et al. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc. Natl Acad. Sci. USA 106, 2136-2141 (2009).
148. Metzker, M. L. Sequencing technologies- the next generation. Nat. Rev. Genet. 11, 31-46 (2010).
149. Kim, S. et al. Targeted lipidomic pathway-guided genetic association with Alzheimer?s disease-relevant endophenotypes. Alzheimers Dement. 9, P680-P681 (2013).
150. Hunt, A. N. Dynamic lipidomics of the nucleus. J. Cell. Biochem. 97, 244-251 (2006).
151. Postle, A. D. & Hunt, A. N. Dynamic lipidomics with stable isotope labelling. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2716-2721 (2009).
152. Bleijerveld, O. B., Houweling, M., Thomas, M. J. & Cui, Z. Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry. Anal. Biochem. 352, 1-14 (2006).
153. Lydic, T. A. et al. Rapid and comprehensive ?shotgun? lipidome profiling of colorectal cancer cell derived exosomes. Methods 87, 83-95 (2015).